

HY-172153 · 50 mg
MedChemExpress · Cat: HY-172153
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/cdk2-in-41.html
Description
CDK2-IN-41 Compound 7a is a CDK2 inhibitor that exerts anticancer activity by binding to CDK2, thereby inhibiting the cell cycle, inducing cytotoxicity, promoting ROS production, and triggering Apoptosis. CDK2-IN-41 exhibits an IC50 of 10 AAasAasAAmuM against acute myeloid leukemia AML HL-60 cells. It holds potential for research in AML-related cancer therapy.







